Fate Therapeutics Inc (NAS:FATE)
$ 3.76 0.1 (2.73%) Market Cap: 428.01 Mil Enterprise Value: 135.15 Mil PE Ratio: 0 PB Ratio: 1.01 GF Score: 58/100

Fate Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 02, 2021 / 03:00PM GMT
Release Date Price: $68.94 (-4.86%)
Operator

Good morning and welcome to the Fate Therapeutics 2021 Annual Meeting of Stockholders. I would now like to hand the call over to Scott Wolchko, CEO of Fate Therapeutics.

J. Scott Wolchko
Fate Therapeutics, Inc. - Founder, CEO, President & Director

Good morning, everyone. I'm happy to welcome you all to the first-ever virtual meeting of the stockholders of Fate Therapeutics, Inc. We have chosen to hold this 2021 Annual Meeting of Stockholders in a virtual format for the health and well-being of our attendees.

I am Scott Wolchko, CEO of Fate Therapeutics, and I will serve as the chair of this meeting. It is just after 8 a.m. Pacific Time and in accordance with the Notice of the Meeting, I now call this meeting to order.

Maggie Wong of Goodwin Procter LLP, our outside legal counsel, will serve as secretary pro tem to record the minutes for this meeting. Before proceeding to the formal business, I would like to recognize and thank our current directors and also the officers of Fate Therapeutics who are joining us today by telephone. We also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot